Bulletin
Investor Alert

Next Avenue

April 22, 2020, 4:20 p.m. EDT

The science behind why older immune systems are more vulnerable to COVID-19

The virus can actually stimulate the airway to produce what’s known as a ‘cytokine’ storm, one expert says

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

By The American Federation for Aging Research


Getty Images
Seniors walk at a shopping center in West Palm Beach, Florida, a state with a high number of older residents.

This article is reprinted by permission from NextAvenue.org . This “Ask the Expert” article is part of an editorial partnership between Next Avenue and The American Federation for Aging Research (AFAR), a national nonprofit organization whose mission is to support and advance healthy aging through biomedical research.

Dr. Sean X. Leng and his laboratory team at Johns Hopkins University School of Medicine study the biology of healthy aging with a focus on chronic inflammation in late-life decline. The lab also studies “immunosenescence” — the decline in immune function as we age. Leng’s team is interested in the relationship between immunosenescence and the basic biological and physiological changes related to aging and frailty in the human immune system.

A professor of medicine, molecular microbiology and immunology and a board-certified geriatrician at Johns Hopkins, Leng is also president of the Milstein Medical Asian American Partnership Foundation, which works to improve world health by developing mutually beneficial partnerships between the U.S. and China, as well as greater Asia.

We recently talked with Leng — a 2006 Paul B. Beeson Emerging Leaders Career Development Award in Aging recipient — about the role of immunosenescence in the COVID-19 pandemic, and how a geroscience approach can help address the problem.

AFAR: As a researcher in the field of aging research who has studied viral infections and immune function, what have we learned from the COVID-19 pandemic about how it effects older adults?

Dr. Sean X. Leng: The thing that’s most pertinent to aging and gerontologists is that older adults are at the greatest risk of hospitalization, winding up in the intensive care unit (ICU) and death from COVID-19. The case fatality rate is far higher among older adults than among the young and middle-aged.

When you look at the data from China through Feb. 11, for those in their 80s and older, the case fatality rate is 14.8%, compared to basically zero among children under the age of 10. In Italy, as of March 17, the case fatality rate for those over age 80 was 20.2%, compared to zero for those age 29 and younger. It should be noted that older adults account for a much higher proportion of Italy’s population (22.8%) than in China (11.9%). This may explain why Italy has a much higher overall case fatality rate than China.

And in the United States, according to the Centers for Disease Control and Prevention, as of March 18, 45% of hospitalizations, 53% of ICU admissions and 80% of deaths associated with COVID-19 were among adults age 65 and older. And the highest percentage was among those age 85 and older. Clearly, older adults are the ones most vulnerable to COVID-19.

What role does decline in immune function as we age, known as immunosenescence, play in making aging the greatest risk factor for severe COVID-19 and deaths?

I think there are two points in terms of older adults’ vulnerability to the severe disease.

One is that our overall immune defense decreases as we age. To put it in simple terms, because of the decline in immune function, if even one viral particle gets into the airways of an older adult, it may be enough for the virus to survive and grow there because of the decline in immune function. For younger individuals, if you have a very strong immune system, the body may be able to kill that virus even if more particles get in.

The other aspect is what we call immune dysregulation. Some of the initial research shows that the virus can actually stimulate the airway to produce what’s known as a ‘cytokine’ storm. Cytokines are small protein molecules, or peptides, that play an important role both in the acute inflammatory response and also in the immune response.

Because the immune system, like other systems in our bodies, is highly regulated, the production of excess cytokines can cause tissue damage. It’s an overreaction to the virus. As in the pathogenesis of sepsis, a cytokine storm, in some cases, can lead to hypotension (low blood pressure), circulation collapse and multiorgan failure.

Page 1 Page 2
This Story has 0 Comments
Be the first to comment
More News In
Retirement

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.